Analysts think ELUT stock price could increase by 149%
Aug 31, 2024, 6:25 AM
-5.87%
What does ELUT do
Elutia is a biotechnology company based in Silver Spring, Maryland, employing 54 people and specializing in Device Protection, Women’s Health, and Cardiovascular products. It went public on October 8, 2020, selling innovative medical solutions such as CanGaroo and SimpliDerm.
4 analysts think ELUT stock price will increase by 149.39%. The current median analyst target is $10.20 compared to a current stock price of $4.09. The lowest analysts target is $10.10 and the highest analyst target is $10.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
